Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ADMA Biologics' shares surge after intravenous immune globulin drug product Asceniv gains FDA approval

firstwordpharmaApril 02, 2019

Tag: FDA , ADMA Biologics , IVIG

PharmaSources Customer Service